Jaguar Health (JAGX) Enterprise Value (2016 - 2025)
Jaguar Health (JAGX) has disclosed Enterprise Value for 11 consecutive years, with -$4.8 million as the latest value for Q3 2025.
- On a quarterly basis, Enterprise Value rose 65.21% to -$4.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.8 million, a 65.21% increase, with the full-year FY2024 number at -$8.8 million, down 34.59% from a year prior.
- Enterprise Value was -$4.8 million for Q3 2025 at Jaguar Health, down from -$3.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3.2 million in Q3 2023 to a low of -$32.2 million in Q1 2021.
- A 5-year average of -$11.1 million and a median of -$9.9 million in 2021 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: tumbled 2554.32% in 2021, then surged 79.76% in 2025.
- Jaguar Health's Enterprise Value stood at -$16.8 million in 2021, then soared by 68.9% to -$5.2 million in 2022, then dropped by 24.99% to -$6.5 million in 2023, then tumbled by 34.59% to -$8.8 million in 2024, then surged by 45.47% to -$4.8 million in 2025.
- Per Business Quant, the three most recent readings for JAGX's Enterprise Value are -$4.8 million (Q3 2025), -$3.3 million (Q2 2025), and -$6.6 million (Q1 2025).